The Impact of IVIG Treatment on Critical Illness Polyneuropathy and/or Myopathy in Patients With MOF and SIRS/Sepsis

Stopped The trial was terminated early due to futility in reaching the primary endpoint.

Conditions

• Polyneuropathies

Interventions

• DRUG: IgM-enriched Intravenous Immunoglobulins
• DRUG: Human Albumin

Sponsor

Medical University of Vienna

Collaborators

• [object Object]
• [object Object]